Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.715 USD | +1.31% | -0.37% | +8.80% |
05-02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.80% | 504M | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-15.93% | 31.09B | |
+52.66% | 24.74B | |
-14.59% | 15.91B | |
-9.12% | 11.96B | |
-14.36% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- JMP Securities Adjusts Arbutus Biopharma Price Target to $9 From $10, Maintains Market Outperform Rating